Table 1: Clinicopathological parameters of UCB ().

ParameterNumber (%)

SexMale102 (82.9%)
Female21 (17.1%)

Age<60 years47 (38.2%)
≥60 years76 (61.8%)

GradeLow grade31 (25.2%)
High grade92 (74.8%)

Muscle invasionNegative42 (34.1%)
Positive77 (62.6%)
Indeterminate4 (3.3%)

Pathological stage (pT)T146 (37.4%)
T247 (38.2%)
T317 (13.8%)
T413 (10.6%)

Nodal metastasisNegative98 (79.7%)
Positive25 (20.3%)

Distant metastasisNegative110 (89.4%)
Positive13 (10.6%)

Lymphovascular invasionNegative101 (82.1%)
Positive22 (17.9%)

Anatomical stageI43 (35%)
II35 (28.5%)
III14 (11.4%)
IV31 (25.2%)

Local disease recurrenceNegative83 (67.5%)
Positive40 (32.5%)

SurvivalAlive87 (70.7%)
Dead36 (29.3%)

T1: tumor invades subepithelial connective tissue; T2: tumor invades muscularis propria; T3: tumor invades perivesical tissue; T4: tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, or abdominal wall; stage I: T1, N0, and M0; stage II: T2, N0, and M0; stage III: T3 or T4a, N0, and M0; stage IV: any T and N1-3 or M1.